DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis

Abstract

BackgroundC-X-C motif ligand 8 (CXCL8), known as a proinflammatory chemokine, exerts multiple effects on the proliferation, invasion, and migration of tumor cells via the autocrine or paracrine manner. Conversely, the human Dachshund homologue 1 (DACH1) is recognized as a tumor suppressor which retards the progression of various cancers. In prostate cancer, it has been demonstrated that DACH1 was negatively correlated with the expression of CXCL8 and able to antagonize the effects of CXCL8 on cellular migration. Herein, we explored the mechanisms by which DACH1 regulated the CXCL8 in non-small cell lung cancer (NSCLC).MethodsPublic microarray and Kaplan-Meier plotter datasets were analyzed. Blood serum samples from lung adenocarcinoma (ADC) patients were collected for enzyme-linked immunosorbent assay (ELISA) analysis. Immunohistochemical staining was conducted on tissue microarray. Cell lines with stable expression of DACH1 were established, and relative gene expression was measured by Western blot, ELISA, real-time PCR, and human cytokine array. Correspondingly, cell lines transfected with shDACH1 were established, and relative gene expression was measured by real-time PCR and immunofluorescence array. Functional studies were performed by transwell and xenograft mice models. Luciferase reporter gene assay was applied to measure the regulation of DACH1 on CXCL8.ResultsOur study indicated that CXCL8 both at the mRNA and protein level was associated with the high tumor burden of ADC. Correlational analyses in ADC cell lines and ADC tissues showed that DACH1 was inversely correlated with CXCL8. Meanwhile, patients with high DACH1 expression and low CXCL8 expression had prolonged time to death and recurrence. Moreover, we verified the inhibitory effects of DACH1 on CXCL8 both in vitro and in vivo. Mechanism studies proved that DACH1 transcriptionally repressed CXCL8 promoter activity through activator protein-1 (AP-1) and nuclear transcription factor-kappa B (NF-κB) sites.ConclusionsOur study proved that CXCL8 acted as an unfavorable factor promoting to tumor progression and poor prognosis of ADC, while DACH1 antagonized CXCL8 to provide a favorable survival of ADC patients. Double detection of DACH1 and CXCL8 may provide a precise information for further evaluating the prognosis of ADC patients.

Astragalus polysaccharides alleviates LPS‐induced inflammation via the NF‐κB/MAPK signaling pathway

“…APS reduced the expression levels of chemokines and proinflammatory factors induced by LPS in IPEC‐J2 cells. The chemokines CXCL2 and CXCL8 are induced by proinflammatory cytokines TNF‐α and IL‐1β (Liu et al, 2018; Maeda et al, 2015). In addition, TNF‐α also promotes the production of IL‐6, causing chronic inflammation (Tanaka, Narazaki, & Kishimoto, 2014).…”

Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis

“…More alterations related to LUAD are continually discovered. For example, Keap1/Nrf2 and Dach1/Eya/Six signaling pathways are involved in the oncogenesis and therapeutic resistance of NSCLC [21][22][23]. It is generally believed that due to the high heterogeneity in genome and complex mutation spectrum, genetic alterationguided molecular targeted therapy has a long way to go.…”

SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1

“…Commercially available tissue microarray (TMA) slides (TH8010 and TH802a, US Biomax, Inc.) were purchased for immunohistochemistry (IHC) analysis. Specific primary antibodies against SIX1 (Sigma, USA) and EYA1 (Proteintech, China) were used for IHC with a 2-step protocol (21). Whole slide image capture was performed on the EVOS auto cell image system (Life technology, USA).…”